Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$210 Mln
P/E Ratio
--
P/B Ratio
58.44
Industry P/E
--
Debt to Equity
8.36
ROE
-2.13 %
ROCE
-61.49 %
Div. Yield
0 %
Book Value
0.05
EPS
-0.86
CFO
$-120.99 Mln
EBITDA
$-167.75 Mln
Net Profit
$-91.54 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Oncology Institute Inc (TOI)
| 777.02 | 172.03 | 352.95 | 127.73 | -29.70 | -- | -- |
|
BSE Sensex*
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
|
|---|---|---|---|
|
Oncology Institute Inc (TOI)
| -84.62 | 23.64 | -83.08 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 134.97 | 11,202.40 | 12.44 | 159.08 | |
| 99.00 | 9,680.15 | 21.41 | 24.54 | |
| 114.68 | 10,419.65 | 3.38 | 110.75 | |
| 161.30 | 10,240.08 | 9.34 | 17.71 |
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services,... in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. Address: 18000 Studebaker Road, Cerritos, CA, United States, 90703 Read more
Executive Chairman of the Board
Mr. Richard Alan Barasch
Executive Chairman of the Board
Mr. Richard Alan Barasch
Headquarters
Cerritos, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Oncology Institute Inc (TOI) stood at $ 173 Mln as on 31-Dec-24
The share price of Oncology Institute Inc (TOI) is $2.71 (NASDAQ) as of 22-Apr-2025 16:00 EDT. Oncology Institute Inc (TOI) has given a return of -29.7% in the last 3 years.
Oncology Institute Inc (TOI) has a market capitalisation of $ 210 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Oncology Institute Inc (TOI) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Oncology Institute Inc (TOI) and enter the required number of quantities and click on buy to purchase the shares of Oncology Institute Inc (TOI).
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California. Address: 18000 Studebaker Road, Cerritos, CA, United States, 90703
The CEO & director of Mr. Richard Alan Barasch. is Oncology Institute Inc (TOI), and CFO & Sr. VP is Mr. Richard Alan Barasch.
There is no promoter pledging in Oncology Institute Inc (TOI).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,137
|
|
|
1,132
|
|
|
1,132
|
|
|
1,037
|
| Oncology Institute Inc (TOI) | Ratios |
|---|---|
|
Return on equity(%)
|
-213.36
|
|
Operating margin(%)
|
-14.53
|
|
Net Margin(%)
|
-16.44
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Oncology Institute Inc (TOI) was $0 Mln.
$0.32
(
